Pulmonary impairment after tuberculosis and its contribution to TB burden

Jotam G Pasipanodya, Scott Jn McNabb, Peter Hilsenrath, Sejong Bae, Kristine Lykens, Edgar Vecino, Guadalupe Munguia, Thaddeus L Miller, Gerry Drewyer, Stephen E Weis, Jotam G Pasipanodya, Scott Jn McNabb, Peter Hilsenrath, Sejong Bae, Kristine Lykens, Edgar Vecino, Guadalupe Munguia, Thaddeus L Miller, Gerry Drewyer, Stephen E Weis

Abstract

Background: The health impacts of pulmonary impairment after tuberculosis (TB) treatment have not been included in assessments of TB burden. Therefore, previous global and national TB burden estimates do not reflect the full consequences of surviving TB. We assessed the burden of TB including pulmonary impairment after tuberculosis in Tarrant County, Texas using Disability-adjusted Life Years (DALYs).

Methods: TB burden was calculated for all culture-confirmed TB patients treated at Tarrant County Public Health between January 2005 and December 2006 using identical methods and life tables as the Global Burden of Disease Study. Years of life-lost were calculated as the difference between life expectancy using standardized life tables and age-at-death from TB. Years lived-with-disability were calculated from age and gender-specific TB disease incidence using published disability weights. Non-fatal health impacts of TB were divided into years lived-with-disability-acute and years lived-with-disability-chronic. Years lived-with-disability-acute was defined as TB burden resulting from illness prior to completion of treatment including the burden from treatment-related side effects. Years lived-with-disability-chronic was defined as TB burden from disability resulting from pulmonary impairment after tuberculosis.

Results: There were 224 TB cases in the time period, of these 177 were culture confirmed. These 177 subjects lost a total of 1189 DALYs. Of these 1189 DALYs 23% were from years of life-lost, 2% were from years lived-with-disability-acute and 75% were from years lived-with-disability-chronic.

Conclusions: Our findings demonstrate that the disease burden from TB is greater than previously estimated. Pulmonary impairment after tuberculosis was responsible for the majority of the burden. These data demonstrate that successful TB control efforts may reduce the health burden more than previously recognized.

Figures

Figure 1
Figure 1
Years of-life-lost (YLL), Years lived-with-disability-acute (YLD-Acute), Years lived-with-disability-chronic (YLD-Chronic) and Total Disability-Adjusted Life Years (DALY), for males and females. Total = YLL + YLD-Acute + YLD-Chronic.
Figure 2
Figure 2
Racial Distribution of TB burden stratified by age groups for the 177 culture confirmed Tuberculosis patients seen between January 1, 2005 and December 31, 2006, Tarrant County, Texas.
Figure 3
Figure 3
Sensitivity analysis: comparisons of the effects of varying the discount rates from 0 to 10%, on total TB Burden in DALY*. *Uniform age weights were applied throughout
Figure 4
Figure 4
Comparison of the effects of using Texas life-tables instead of the Japanese life-tables on total tuberculosis burden.

References

    1. World Health Organization. Geneva: WHO. Estimated incidence, prevalence and TB mortality; 2004. [homepage on the internet]. [one screen].
    1. CDC Reported Tuberculosis in the United States (2003) Reported Tuberculosis in the United States, 2003. Tuberculosis Case Rates and Death Rates United States, 1953-2003. U. S. Department of Health and Human Services. Centers for Disease Control and Prevention; 2004. Atlanta, GA. 50 Years of TB Surveillance.
    1. The World health report 2000. health systems: improving performance. ISBN 92 4 156198 X NLM Classification: WA 540.1. World Health Organization. Geneva;
    1. Jamison DT, Breman JG, Measham AR. Diseases Control Priorities in Developing Countries. 2. Oxford University Press & the World Bank; pp. 3–35. ISBN-10-0-8213-0821361791. 289-311.
    1. Sodeman WA, Sodeman TM, eds. Pathologic physiology: mechanisms of disease. 7. Philadelphia: PA. W.B. Saunders Company; 1985. pp. 467–8.
    1. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest. 1998;113:933–43. doi: 10.1378/chest.113.4.933.
    1. Hnzido E, Singh T, Churchyard G. Chronic pulmonary function impairment by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–38. doi: 10.1136/thorax.55.1.32.
    1. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE. Pulmonary Impairment After Tuberculosis. Chest. 2007;131:1817–1824. doi: 10.1378/chest.06-2949.
    1. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, Weis SE. Using the St George's Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest. 2007;132:1591–1598. doi: 10.1378/chest.07-0755.
    1. Menezes AMB, Hallal PC, Perz-Padilla R, Jardin JRB, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J. Victora CG for the Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30:1180–1185. doi: 10.1183/09031936.00083507.
    1. Mary Dempsey. Decline in Tuberculosis: the death rate fails to tell the entire story. American Review of Tuberculosis. 1947;56:157–164.
    1. Nunn P, Harries A, Godfrey-Faussett P. The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. Bulletin of the World Health Organization. 2002;80:471–6.
    1. Mathers CO, Vos T, Lopez AD, Salomon J, Ezzati M, (ed) National Burden of Disease Studies: A Practical Guide. 2. World Health Organization. Geneva; 2001. pp. 5–16. 80-116.
    1. Murray CJL, Lopez A, eds. Global Burden of disease and injury series. Vol. 1. Cambridge: Harvard University Press; 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020; pp. 1–99. ISBN 0-674-355448-6.
    1. Mokdad AH, Marks JS, Stroup DF, Gerderding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45. doi: 10.1001/jama.291.10.1238.
    1. Mathers CD, Theo Vos E, Stevenson CE, Begg SJ. The Burden disease and injury in Australia. Bulletin of the World Health Organization. 2001;79(11)
    1. Peabody JW, Shimakhada R, Tan C, Luck J. The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines. Oxford University Press; 2005. doi:10.1093/heapol/czi041.
    1. Melse JM, Essink-Bot ML, Kramers PGN, Hoeymans N. Dutch Burden of Disease Group. A National Burden of Disease Calculation: Dutch Disability-Adjusted Life-Years. American Journal of Public Health. 2000;90(8):1241–1247. doi: 10.2105/AJPH.90.8.1241.
    1. Norman R, Bradshaw D, Schneider M, Pieterse D, Groenewald P. Methodological Note. Cape Town: South African Medical Research Council; 2006. Revised Burden of Disease Estimates for the Comparative Risk Factor Assessment, South Africa 2000.
    1. Victoria Burden of Disease Study - Morbidity. Human Services. Public Health Division; 1999. ISBN No: 0 7311 6043 6.
    1. Chapman G, Hansen KS, Jelsma J, Ndlovu C, Piotti B, Byskov J, Vos T. The burden of disease in Zimbabwe in 1997 as measured by disability-adjusted life years lost. Trop Med Int Health. 2006;11(5):660–71. doi: 10.1111/j.1365-3156.2006.01601.x.
    1. McKenna MT, Michaud CM, Murray CJL, Marks JS. Assessing Burden of disease in the United States Using Disability Adjusted Life Years. American Journal of Preventive Medicine. 2005;28(5) doi: 10.1016/j.amepre.2005.02.009.
    1. Kominski GF, Simon PA, Ho A, Luck J, Lim YW, Fielding JE. Assessing the Burden of Disease in Los Angeles County Using Disability-Adjusted Life Years. Public Health Reports. 2002;117
    1. US Census Bureau, 2006. retrieved on October 10, 2006.
    1. Office of the Secretary of State, State of Texas [homepage on the internet] Austin, Texas. Texas Administrative Code Title 25, Part 1, Chapter 97 [about 2 screens]
    1. Tarrant County Public Health Department. Division of TB Elimination. Annual Reports 2006 and 2007. Gerry Drewyer, Program Manager;
    1. Coale A, Guo G. Revised Regional model life tables at very low levels of mortality. Population Index. 1989;55(4):613–643. doi: 10.2307/3644567.
    1. Lopez AD, Salomon J, Ahmad O, Murray CJL. Life tables for 191 countries: data, methods, and results. Geneva: WHO (GPE Discussion Paper No. 9); 2000.
    1. Texas Department of State Health Services, Center for Health Statistics. Vital Statistics 2006 Annual Report. Life Tables, Table 24, Texas 2006. Last Accessed November 6th, 2009.
    1. Fox-Rusby JA, Hanson K. Calculating and presenting disability adjusted life years in cost-effectiveness analysis. Health Policy and Planning. 2001;16(3):326–331. doi: 10.1093/heapol/16.3.326.
    1. World Health Organization. International statistical classification of diseases and health related problems. 10. WHO. Geneva; 1992.
    1. Gold MR, Siegel JE, Weinstein MC, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1339–1341. doi: 10.1001/jama.276.16.1339.
    1. Christopher Dye and Katherine Floyd, "Tuberculosis.". Disease Control Priorities in Developing Countries. 2. New York: Oxford University Press; 2006. pp. 289–312. DOI: 10.1596/978-0-821-36179-5/Chpt-16. (Figure sixteen.one)
    1. Styblo K. Recent advances in epidemiological research in Tuberculosis. Adv Tuberc Res. 1980;20:1–63.
    1. Taylor Z. The cost-effectiveness of screening for latent tuberculosis. The International Journal of Tuberculosis and Lung Disease. 2000;4(Supplement 2):S127–S133. (1).
    1. Payam N, Madhukar P, Philip C. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006;3:103–110. doi: 10.1513/pats.200511-119JH.
    1. Collard David. Pigou and future generations: a Cambridge tradition. Cambridge Journal of Economics. 1996;20:585–597.
    1. Ramsey F. A mathematical theory of saving. Economic Journal. 1928;38:543–559. doi: 10.2307/2224098.
    1. Jamison DT, Jamison JS. DCPP Working Paper No. 4. DCPP Working Papers. Bethesda, MD, Disease Control Priorities Project, Fogarty International Center, National Institutes of Health; 2003. Discounting.
    1. Andersson GBJ, Cocchiarella L, eds. Guides to the Evaluation of Permanent Impairment. 5. AMA Press. Chicago. IL; 2000. pp. 2–15. ISBN 1-57947-085-8. 87-112, 565-586.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit